CHD
48
-5
MAT
54
3
WHR
57
2
FITB
60
2
DFS
59
5
TGT
52
2
DE
45
5
PEG
71
-3
CMG
54
4
GRMN
52
2
AA
45
2
ADM
36
6
PGR
65
-3
ADI
61
5
KEY
54
6
MTCH
48
4
NEE
47
-5
ADSK
67
2
MRO
55
4
FAST
49
3
CHD
48
-5
MAT
54
3
WHR
57
2
FITB
60
2
DFS
59
5
TGT
52
2
DE
45
5
PEG
71
-3
CMG
54
4
GRMN
52
2
AA
45
2
ADM
36
6
PGR
65
-3
ADI
61
5
KEY
54
6
MTCH
48
4
NEE
47
-5
ADSK
67
2
MRO
55
4
FAST
49
3
Financhill
Back

Entrada Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Buy
51

TRDA
Entrada Therapeutics

Last Price:
14.68
Seasonality Move:
13.84%
Sell
49

CPRX
Catalyst Pharmaceuticals

Last Price:
20.75
Seasonality Move:
-9.09%
Buy
51
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $15.00. The Score for TRDA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.36. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $15.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: 57001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 16.79) Sell
Bollinger Bands (100): (14.13 - 16.59) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 70.42 Buy
Chaikin Money Flow: 901932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.72 - 20.62) Buy
Bollinger Bands (100): (15.22 - 19.16) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.6 Buy
20-day SMA: 15.54 Sell
50-day SMA: 15.95 Sell
200-day SMA: 14.68 Buy
8-day EMA: 14.67 Buy
20-day EMA: 15.18 Sell
50-day EMA: 15.47 Sell
200-day EMA: 14.99 Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.25 Buy
20-day SMA: 20.17 Buy
50-day SMA: 18.73 Buy
200-day SMA: 16.16 Buy
8-day EMA: 20.45 Buy
20-day EMA: 20.02 Buy
50-day EMA: 18.92 Buy
200-day EMA: 16.55 Buy

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):